Swiss Cannabis Pilot Shows Strong Results, Bolstering Case for Federal Legalization

Zurich’s pioneering “Züri Can” cannabis pilot project is reporting encouraging early results, leading city officials to apply for a two-year extension until 2028. This development arrives as Switzerland’s Federal Government is actively considering a draft law that could usher in nationwide adult-use cannabis legalization, potentially positioning the country as a European leader in regulated markets….

Read More

Pennsylvania Senate Panel Greenlights Cannabis Control Board, Eyes Overhaul of Medical Marijuana and Hemp Oversight

HARRISBURG, PA – A significant legislative advancement for Pennsylvania’s burgeoning cannabis sector occurred Tuesday as the Senate Law & Justice Committee overwhelmingly approved Senate Bill 49 (SB 49). This bipartisan legislation would establish a dedicated Cannabis Control Board (CCB), tasked with consolidating oversight of the state’s medical marijuana program and regulating the growing market of…

Read More

ACCM Launches Landmark Initiative with Insurers to Dramatically Expand Medical Cannabis Access and Affordability

WASHINGTON D.C. – The American Council of Cannabis Medicine (ACCM) has unveiled a sweeping national initiative, dubbed the “Elevated States Program,” designed to significantly broaden access to and affordability of medically guided cannabis treatments for millions of Americans. Announced on October 21, 2025, this groundbreaking effort marks a pivotal moment, forging new partnerships with major…

Read More

Auxly Cannabis Group Set to Present Key Growth Strategies at Planet MicroCap Showcase: Toronto

Auxly Cannabis Group Inc., a leading Canadian consumer packaged goods company in the cannabis products market, is slated to present at the highly anticipated Planet MicroCap Showcase in Toronto. The event, scheduled for Wednesday, October 22, 2025, will feature CEO Hugo Alves delivering a presentation and hosting a question-and-answer session at 11:30 AM EST. The…

Read More

Curaleaf Secures Landmark $100 Million Credit Facility, Bolstering Cannabis Sector Access to Capital

Curaleaf Secures Landmark $100 Million Credit Facility, Bolstering Cannabis Sector Access to Capital STAMFORD, Conn. – October 14, 2025 – Curaleaf Holdings, Inc., a leading international provider of consumer cannabis products, today announced a significant expansion of its revolving credit facility with Needham Bank, increasing its borrowing capacity to $100 million. This move, which extends…

Read More

South Korea’s Outdated Cannabis Laws: Patients Suffer, Industry Stalls Amidst Global Advancements

South Korea finds itself increasingly out of step with global shifts in cannabis policy, grappling with outdated regulations that severely restrict access for patients, stifle domestic innovation, and strain its public healthcare system. Despite a partial legalization of medical cannabis in 2018, the country’s stringent approach, which continues to classify even non-psychoactive compounds like CBD…

Read More

JP Brand Advisors and Canopy USA Forge Strategic Partnership to Supercharge Wana Hemp Beverage and Gummy Distribution Nationwide

JP Brand Advisors (JPBA) and Canopy USA announced a significant strategic partnership on October 7, 2025, aimed at expanding the nationwide distribution of Wana’s popular hemp-based beverages and gummies. This collaboration brings together JPBA’s extensive expertise in traditional beverage distribution with Canopy USA’s established presence in the U.S. cannabis market, signaling a concerted effort to…

Read More

Texas TABC Enforces Emergency Rules: Age Gate for Hemp THC Products Now Active

Texas is implementing significant new regulations on consumable hemp THC products, with the Texas Alcoholic Beverage Commission (TABC) issuing emergency rules that took effect immediately upon publication and will be enforced starting October 1, 2025. These new measures, spurred by Governor Greg Abbott’s Executive Order GA-56, establish a strict age gate for sales and mandate…

Read More

Anebulo Pharmaceuticals Initiates Phase 1 Trial for IV Cannabis Toxicity Antidote, Bolstered by NIDA Funding

AUSTIN, Texas – Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company, has announced a significant milestone in its drug development program, dosing the first subjects in a Phase 1 single ascending dose (SAD) study of its investigational intravenous (IV) treatment, selonabant. This crucial trial, conducted in healthy young adults, is supported by a collaborative…

Read More